Skip to search.
 FTSE 100 Down 0.15%

Alkermes plc (ALKS)

-NasdaqGS Ticker: 56GVS1/ISIN: IE00B56GVS15
49.79 Up 1.21(2.49%) 21:00
|After Hours: : 49.79 0.00 (0.00%) 21:28 - Nasdaq Real Time Price
Prev Close:48.58
Open:49.41
Bid:49.79 x 100
Ask:49.91 x 100
1y Target Est:51.36
Beta:2.05131
Earnings Date:27 Oct - 31 Oct (Est.)
Day's Range:48.60 - 50.08
52wk Range:27.14 - 80.71
Volume:1,035,335
Avg Vol (3m):830,123
Market Cap:7.55b
P/E (ttm):N/A
EPS (ttm):-1.83
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ALKSUp 2.49%7.55b
LLYUp 1.71%85.35b
GSKUp 0.84%105.29b
ABTUp 1.56%62.23b

Key Statistics

Forward P/E (1 yr):131.03
P/S (ttm):11.03
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.12
Quarterly EPS Est (Sep-16) :-0.03
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):14.25

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products that are designed to address unmet medical needs of patients in various therapeutic areas worldwide. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback